Cerca una sperimentazione clinica
Altra/e opzione/i di ricerca
5 Risultato/i
Sperimentazione in fase di reclutamento
= 
; Sperimentazione in corso
= 
; Sperimentazione conclusa
= 
; Finanziato da un ente associato a IRDiRC = 
; Studio che coinvolge i membri delle ERN in almeno due Stati = 
Sperimentazioni cliniche nazionali
FRANCIA
ILE-DE-FRANCE
PARIS
A Phase I/II, Non Randomized, Monocentric Open-label Study of Autologous CD34+ Cells Transduced With the G1XCGD Lentiviral Vector in Patients With X-Linked Chronic Granulomatous Disease
Hôpital Necker-Enfants Malades
Service d'Immuno-hématologie pédiatrique
GERMANIA
Hessen
FRANKFURT AM MAIN
Phase I/II G1XCGD.01 Sudy: Phase I/II, Non Randomized, Multicenter, Open-label Study of g1xcgd (Lentiviral Vector Transduced cd34+ Cells) in Patients with X-linked Chronic Granulomatous Disease - DE
Universitätsklinikum Frankfurt
Medizinische Klinik II - Hämatologie, Onkologie, Hämostaseologie, Rheumatologie, Infektiologie
GIAPPONE
JAPAN
ADDRESS : NOT PROVIDED - JP
Double-blind placebo-controlled clinical trial of thalidomide for chronic granulomatous disease-associated colitis
Institution: Information not provided - JP
REGNO UNITO; GRAN BRETAGNA
Greater London
LONDON
A phase I/II, non randomized, multicenter, open-label study of G1XCGD (lentiviral vector transduced CD34+ cells) in patients with X-Linked Chronic Granulomatous Disease - UK
Great Ormond Street Hospital
Molecular and Cellular Immunology Unit
Sperimentazioni cliniche internazionali
FRANCIA
ILE-DE-FRANCE
EVRY